Astellas Pharma Inc.
ALPMFOTCHealthcare● Active
$14.48
+$0.28(+1.99%)
Market Cap$25.9B
P/E Ratio—
52W High$17.85
52W Low$9.34
Astellas Pharma Inc.（ALPMF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ALPMF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.293T | $0.031T | $0.017T | $0.132T | $0.157T |
| Depreciation & Amort. | $0.196T | $0.199T | $0.158T | $0.106T | $0.080T |
| Stock-Based Comp. | $0.000T | $0.000T | $0.000T | $0.000T | $0.000T |
| Change in Working Capital | $0.028T | ($0.166T) | ($0.087T) | ($0.024T) | $0.006T |
| Net Cash from Operations | $0.570T | $0.195T | $0.172T | $0.328T | $0.257T |
| Investing Activities | |||||
| Capital Expenditure | ($0.058T) | ($0.057T) | ($0.082T) | ($0.089T) | ($0.076T) |
| Purchases of Investments | $0.000T | $0.000T | $0.000T | $0.000T | ($0.006T) |
| Sales of Investments | $0.000T | $0.013T | $0.000T | $0.013T | $0.006T |
| Net Cash from Investing | ($0.073T) | ($0.089T) | ($0.846T) | ($0.085T) | ($0.062T) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.001T) | ($0.007T) | ($0.011T) | ($0.061T) | ($0.051T) |
| Dividends Paid | ($0.137T) | ($0.129T) | ($0.117T) | ($0.100T) | ($0.085T) |
| Debt Issued / Repaid | ($0.269T) | ($0.089T) | $0.771T | ($0.015T) | ($0.060T) |
| Net Cash from Financing | ($0.407T) | ($0.261T) | $0.614T | ($0.196T) | ($0.216T) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.512T | $0.137T | $0.090T | $0.239T | $0.181T |
| FCF Margin %(computed) | 23.77% | 7.17% | 5.61% | 15.75% | 13.96% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · JPY · T
深入了解Astellas Pharma Inc.
关于Astellas Pharma Inc.（ALPMF）现金流量表
Astellas Pharma Inc. 2026财年经营活动现金流$569.82B，自由现金流$511.73B（FCF利润率23.77%），资本支出($58.09B)。
常见问题
ALPMF · 4 问Astellas Pharma Inc. 2026财年自由现金流$511.73B，同比up273.0%。
ALPMF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10